[ Price : $8.95]
Payer and reimbursement issuesnot sciencepose the greatest potential impediment to providing new therapies for patients with rare ...[ Price : $8.95]
FDA extends a continuing clinical hold on Insmed's Arikace (liposomal amikacin for inhalation) in patients with non-tuberculous my...[ Price : $8.95]
Par Pharmaceutical files a declaratory judgment complaint and a motion for preliminary injunction against FDA over off-label restr...[ Price : $8.95]
Federal Register Notice: FDAs Circulatory System Devices Panel will meet 12/7-8 to discuss a Medtronic PMA supplement and a Cardio...[ Price : $8.95]
FDA approves an ApoPharma NDA Ferriprox (deferiprone) to treat thalassemia patients who've had a blood transfusion that caused iro...[ Price : $8.95]
Panelists at the U.S. Conference on Rare Diseases and Orphan Products explore the role and evolution of private research foundatio...[ Price : $8.95]
This week's New England Journal of Medicine includes an article by Harvard professors that examines the history of, and potential ...[ Price : $8.95]
Depomed says it will meet with FDA to discuss a planned NDA after announcing positive clinical trial results from a Phase 3 study ...